BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24702224)

  • 1. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures.
    Dammeyer P; Hellberg V; Wallin I; Laurell G; Shoshan M; Ehrsson H; Arnér ES; Kirkegaard M
    Acta Otolaryngol; 2014 May; 134(5):448-54. PubMed ID: 24702224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.
    Hellberg V; Wallin I; Eriksson S; Hernlund E; Jerremalm E; Berndtsson M; Eksborg S; Arnér ES; Shoshan M; Ehrsson H; Laurell G
    J Natl Cancer Inst; 2009 Jan; 101(1):37-47. PubMed ID: 19116379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.
    Saito T; Manabe Y; Saito H
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):250-5. PubMed ID: 8587776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
    Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
    Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model.
    Li KH; Zhao YY; Cheng HL; Yang JJ; Chien CY
    Environ Toxicol; 2024 Jul; 39(7):4058-4065. PubMed ID: 38661261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin ototoxicity in rat cochlear organotypic cultures.
    Ding D; He J; Allman BL; Yu D; Jiang H; Seigel GM; Salvi RJ
    Hear Res; 2011 Dec; 282(1-2):196-203. PubMed ID: 21854840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-induced ototoxicity in organotypic cochlear cultures occurs independent of gap junctional intercellular communication.
    Abitbol J; Beach R; Barr K; Esseltine J; Allman B; Laird D
    Cell Death Dis; 2020 May; 11(5):342. PubMed ID: 32393745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DHCR24 increases the cisplatin-induced damage to cochlear hair cells in vitro.
    Tian KY; Chang HM; Wang J; Qi MH; Wang WL; Qiu Y; Liang K; Chen FQ; Zha DJ; Qiu JH
    Neurosci Lett; 2019 Jul; 706():99-104. PubMed ID: 31091460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
    Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
    Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
    Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
    Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin metabolites and their toxicity on isolated cochlear outer hair cells in vitro.
    Saito T; Yamada T; Manabe Y; Yamamoto T; Saito H
    Acta Otolaryngol; 1996 Jul; 116(4):561-5. PubMed ID: 8831842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of the neurotrophic ACTH(4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin.
    de Groot JC; Hamers FP; Gispen WH; Smoorenburg GF
    Hear Res; 1997 Apr; 106(1-2):9-19. PubMed ID: 9112103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
    J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats.
    Madnani D; Li G; Frenz CM; Frenz DA
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):327-31. PubMed ID: 17666265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative ototoxicity of 21 aromatic solvents.
    Gagnaire F; Langlais C
    Arch Toxicol; 2005 Jun; 79(6):346-54. PubMed ID: 15660228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?
    Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
    Hear Res; 2000 Jun; 144(1-2):147-56. PubMed ID: 10831873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.